Enhanced ability of daniplestim and mpo-1 to suppress apoptosis and stimulate cytokine-inducible gene expression

James A. McCubrey, Oussama A. Saleh, Patrick M. Navolanic, Marianne L. Pearce, William L. Blalock, Linda S. Steelman, Carla J. Burrows, John T. Lee, Richard A. Franklin, Parul D. Doshi, John P. McKearn

Research output: Contribution to journalArticle

Abstract

The modified IL-3 receptor agonist, daniplestim. binds to the interleukin-3 (IL-3) receptor-a subunit with 60-fold greater affinity and induces CPU formation 10 to 20-fold better than native IL-3. Myelopoietin-1 (MPO-1 ) binds both the IL-3 and G-CSF receptors. In CPU assays, MPO-1 demonstrated greater stimulation of CFU-GM than the co-addition of native IL-3 & G-CSF. While the in vivo effects of daniplestim and MPO-1 are well described, the mechanisms by which they stimulate growth are not well understood. We have investigated the effects of daniplestim and MPO-1 on the prevention of apoptosis and the induction of gene expression in human hematopoietic OCI-AML and AML193 cell lines. Daniplestim and MPO-1 prevented apoptosis 5 to 10-fold better than native recombinant IL-3 as determined by Annexin V/propidium iodide binding FACS assay and TUNEL assays. Daniplestim and MPO-1 also promoted the maintenance of the mitochondria! membrane potential at 10-fold lower concentrations than native IL-3 or G-CSF. MPO-1 promoted a lower redox potential as higher levels of free radicals were detected than after culture with native IL-3 which could imply increased respiration in MPO-1-treated cells. In addition, the expression of cytokine-regulated genes was examined by Clontech cDNA human cancer array analysis and the expression of the relevant genes confirmed by RT-PCR and western blot analysis. Changes in hybridization levels of 3-fold were considered significant. Increased levels of mRNA transcripts encoding many members of the MAPK pathway were detected after treatment of cells with daniplestim and MPO-1. In contrast, the expression of many Rho/Rac GTP/GDP exchange family members were decreased after treatment with these cytokines. Genes involved in the regulation of the redox potential such as Superoxide dismutase and glutathione synthetase were detected in elevated levels in cytokine treated cells. Many anti-apoptotic genes such as Bcl-XL, Oncostatin M, LIF, Pirn were detected at higher levels in cells treated with MPO-1 than cells treated with the coaddition of IL-3 & G-CSF. cDNAs were detected in 10-fold lower levels in cells cultured in the absence of cytokines. These results suggest that MPO-1 may be able to promote cell growth by inhibiting apoptosis and inducing expression of genes which induce cell proliferation.

Original languageEnglish
JournalBlood
Volume96
Issue number11 PART II
Publication statusPublished - 2000

Fingerprint

Gene expression
Interleukin-3
Apoptosis
Cytokines
Gene Expression
Genes
Granulocyte Colony-Stimulating Factor
Interleukin-3 Receptors
Cells
Assays
Oxidation-Reduction
Program processors
daniplestim
myelopoietin
Glutathione Synthase
Complementary DNA
Granulocyte Colony-Stimulating Factor Receptors
Oncostatin M
Granulocyte-Macrophage Progenitor Cells
Mitochondria

ASJC Scopus subject areas

  • Hematology

Cite this

McCubrey, J. A., Saleh, O. A., Navolanic, P. M., Pearce, M. L., Blalock, W. L., Steelman, L. S., ... McKearn, J. P. (2000). Enhanced ability of daniplestim and mpo-1 to suppress apoptosis and stimulate cytokine-inducible gene expression. Blood, 96(11 PART II).

Enhanced ability of daniplestim and mpo-1 to suppress apoptosis and stimulate cytokine-inducible gene expression. / McCubrey, James A.; Saleh, Oussama A.; Navolanic, Patrick M.; Pearce, Marianne L.; Blalock, William L.; Steelman, Linda S.; Burrows, Carla J.; Lee, John T.; Franklin, Richard A.; Doshi, Parul D.; McKearn, John P.

In: Blood, Vol. 96, No. 11 PART II, 2000.

Research output: Contribution to journalArticle

McCubrey, JA, Saleh, OA, Navolanic, PM, Pearce, ML, Blalock, WL, Steelman, LS, Burrows, CJ, Lee, JT, Franklin, RA, Doshi, PD & McKearn, JP 2000, 'Enhanced ability of daniplestim and mpo-1 to suppress apoptosis and stimulate cytokine-inducible gene expression', Blood, vol. 96, no. 11 PART II.
McCubrey JA, Saleh OA, Navolanic PM, Pearce ML, Blalock WL, Steelman LS et al. Enhanced ability of daniplestim and mpo-1 to suppress apoptosis and stimulate cytokine-inducible gene expression. Blood. 2000;96(11 PART II).
McCubrey, James A. ; Saleh, Oussama A. ; Navolanic, Patrick M. ; Pearce, Marianne L. ; Blalock, William L. ; Steelman, Linda S. ; Burrows, Carla J. ; Lee, John T. ; Franklin, Richard A. ; Doshi, Parul D. ; McKearn, John P. / Enhanced ability of daniplestim and mpo-1 to suppress apoptosis and stimulate cytokine-inducible gene expression. In: Blood. 2000 ; Vol. 96, No. 11 PART II.
@article{46c4734434994148bf6f20bafe2ae944,
title = "Enhanced ability of daniplestim and mpo-1 to suppress apoptosis and stimulate cytokine-inducible gene expression",
abstract = "The modified IL-3 receptor agonist, daniplestim. binds to the interleukin-3 (IL-3) receptor-a subunit with 60-fold greater affinity and induces CPU formation 10 to 20-fold better than native IL-3. Myelopoietin-1 (MPO-1 ) binds both the IL-3 and G-CSF receptors. In CPU assays, MPO-1 demonstrated greater stimulation of CFU-GM than the co-addition of native IL-3 & G-CSF. While the in vivo effects of daniplestim and MPO-1 are well described, the mechanisms by which they stimulate growth are not well understood. We have investigated the effects of daniplestim and MPO-1 on the prevention of apoptosis and the induction of gene expression in human hematopoietic OCI-AML and AML193 cell lines. Daniplestim and MPO-1 prevented apoptosis 5 to 10-fold better than native recombinant IL-3 as determined by Annexin V/propidium iodide binding FACS assay and TUNEL assays. Daniplestim and MPO-1 also promoted the maintenance of the mitochondria! membrane potential at 10-fold lower concentrations than native IL-3 or G-CSF. MPO-1 promoted a lower redox potential as higher levels of free radicals were detected than after culture with native IL-3 which could imply increased respiration in MPO-1-treated cells. In addition, the expression of cytokine-regulated genes was examined by Clontech cDNA human cancer array analysis and the expression of the relevant genes confirmed by RT-PCR and western blot analysis. Changes in hybridization levels of 3-fold were considered significant. Increased levels of mRNA transcripts encoding many members of the MAPK pathway were detected after treatment of cells with daniplestim and MPO-1. In contrast, the expression of many Rho/Rac GTP/GDP exchange family members were decreased after treatment with these cytokines. Genes involved in the regulation of the redox potential such as Superoxide dismutase and glutathione synthetase were detected in elevated levels in cytokine treated cells. Many anti-apoptotic genes such as Bcl-XL, Oncostatin M, LIF, Pirn were detected at higher levels in cells treated with MPO-1 than cells treated with the coaddition of IL-3 & G-CSF. cDNAs were detected in 10-fold lower levels in cells cultured in the absence of cytokines. These results suggest that MPO-1 may be able to promote cell growth by inhibiting apoptosis and inducing expression of genes which induce cell proliferation.",
author = "McCubrey, {James A.} and Saleh, {Oussama A.} and Navolanic, {Patrick M.} and Pearce, {Marianne L.} and Blalock, {William L.} and Steelman, {Linda S.} and Burrows, {Carla J.} and Lee, {John T.} and Franklin, {Richard A.} and Doshi, {Parul D.} and McKearn, {John P.}",
year = "2000",
language = "English",
volume = "96",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "11 PART II",

}

TY - JOUR

T1 - Enhanced ability of daniplestim and mpo-1 to suppress apoptosis and stimulate cytokine-inducible gene expression

AU - McCubrey, James A.

AU - Saleh, Oussama A.

AU - Navolanic, Patrick M.

AU - Pearce, Marianne L.

AU - Blalock, William L.

AU - Steelman, Linda S.

AU - Burrows, Carla J.

AU - Lee, John T.

AU - Franklin, Richard A.

AU - Doshi, Parul D.

AU - McKearn, John P.

PY - 2000

Y1 - 2000

N2 - The modified IL-3 receptor agonist, daniplestim. binds to the interleukin-3 (IL-3) receptor-a subunit with 60-fold greater affinity and induces CPU formation 10 to 20-fold better than native IL-3. Myelopoietin-1 (MPO-1 ) binds both the IL-3 and G-CSF receptors. In CPU assays, MPO-1 demonstrated greater stimulation of CFU-GM than the co-addition of native IL-3 & G-CSF. While the in vivo effects of daniplestim and MPO-1 are well described, the mechanisms by which they stimulate growth are not well understood. We have investigated the effects of daniplestim and MPO-1 on the prevention of apoptosis and the induction of gene expression in human hematopoietic OCI-AML and AML193 cell lines. Daniplestim and MPO-1 prevented apoptosis 5 to 10-fold better than native recombinant IL-3 as determined by Annexin V/propidium iodide binding FACS assay and TUNEL assays. Daniplestim and MPO-1 also promoted the maintenance of the mitochondria! membrane potential at 10-fold lower concentrations than native IL-3 or G-CSF. MPO-1 promoted a lower redox potential as higher levels of free radicals were detected than after culture with native IL-3 which could imply increased respiration in MPO-1-treated cells. In addition, the expression of cytokine-regulated genes was examined by Clontech cDNA human cancer array analysis and the expression of the relevant genes confirmed by RT-PCR and western blot analysis. Changes in hybridization levels of 3-fold were considered significant. Increased levels of mRNA transcripts encoding many members of the MAPK pathway were detected after treatment of cells with daniplestim and MPO-1. In contrast, the expression of many Rho/Rac GTP/GDP exchange family members were decreased after treatment with these cytokines. Genes involved in the regulation of the redox potential such as Superoxide dismutase and glutathione synthetase were detected in elevated levels in cytokine treated cells. Many anti-apoptotic genes such as Bcl-XL, Oncostatin M, LIF, Pirn were detected at higher levels in cells treated with MPO-1 than cells treated with the coaddition of IL-3 & G-CSF. cDNAs were detected in 10-fold lower levels in cells cultured in the absence of cytokines. These results suggest that MPO-1 may be able to promote cell growth by inhibiting apoptosis and inducing expression of genes which induce cell proliferation.

AB - The modified IL-3 receptor agonist, daniplestim. binds to the interleukin-3 (IL-3) receptor-a subunit with 60-fold greater affinity and induces CPU formation 10 to 20-fold better than native IL-3. Myelopoietin-1 (MPO-1 ) binds both the IL-3 and G-CSF receptors. In CPU assays, MPO-1 demonstrated greater stimulation of CFU-GM than the co-addition of native IL-3 & G-CSF. While the in vivo effects of daniplestim and MPO-1 are well described, the mechanisms by which they stimulate growth are not well understood. We have investigated the effects of daniplestim and MPO-1 on the prevention of apoptosis and the induction of gene expression in human hematopoietic OCI-AML and AML193 cell lines. Daniplestim and MPO-1 prevented apoptosis 5 to 10-fold better than native recombinant IL-3 as determined by Annexin V/propidium iodide binding FACS assay and TUNEL assays. Daniplestim and MPO-1 also promoted the maintenance of the mitochondria! membrane potential at 10-fold lower concentrations than native IL-3 or G-CSF. MPO-1 promoted a lower redox potential as higher levels of free radicals were detected than after culture with native IL-3 which could imply increased respiration in MPO-1-treated cells. In addition, the expression of cytokine-regulated genes was examined by Clontech cDNA human cancer array analysis and the expression of the relevant genes confirmed by RT-PCR and western blot analysis. Changes in hybridization levels of 3-fold were considered significant. Increased levels of mRNA transcripts encoding many members of the MAPK pathway were detected after treatment of cells with daniplestim and MPO-1. In contrast, the expression of many Rho/Rac GTP/GDP exchange family members were decreased after treatment with these cytokines. Genes involved in the regulation of the redox potential such as Superoxide dismutase and glutathione synthetase were detected in elevated levels in cytokine treated cells. Many anti-apoptotic genes such as Bcl-XL, Oncostatin M, LIF, Pirn were detected at higher levels in cells treated with MPO-1 than cells treated with the coaddition of IL-3 & G-CSF. cDNAs were detected in 10-fold lower levels in cells cultured in the absence of cytokines. These results suggest that MPO-1 may be able to promote cell growth by inhibiting apoptosis and inducing expression of genes which induce cell proliferation.

UR - http://www.scopus.com/inward/record.url?scp=33748553683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748553683&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33748553683

VL - 96

JO - Blood

JF - Blood

SN - 0006-4971

IS - 11 PART II

ER -